BG
LJPC

BlackRock Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

BlackRock Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$76K Buy
4,299
+567
+15% +$10.9K ﹤0.01% 2872
2016
Q3 		$89K Buy
3,732
+246
+7% +$4.63K ﹤0.01% 2837
2016
Q2 		$56K Sell
3,486
-82
-2% -$1.47K ﹤0.01% 2895
2016
Q1 		$74K Buy
3,568
+1,869
+110% +$33.3K ﹤0.01% 2839
2015
Q4 		$46K Buy
+1,699
New +$46.3K ﹤0.01% 2835

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Group's LJPC Position: Q4 2016 in Review

BlackRock Group increased its La Jolla Pharmaceutical Company (LJPC) stake by 15% in Q4 2016, buying an estimated $10.9K and bringing the position to 4,299 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

BlackRock Group first reported a position in LJPC in Q4 2015 and has held it in 5 quarters since. The position peaked at $89K in Q3 2016. 62 funds tracked by Wall St. Rank hold LJPC as of Q4 2016.

  • BlackRock Group held 4,299 shares of La Jolla Pharmaceutical Company worth $76K as of Q4 2016.
  • BlackRock Group bought 567 La Jolla Pharmaceutical Company shares in Q4 2016, an estimated $10.9K.
  • La Jolla Pharmaceutical Company made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2872 holding.
  • BlackRock Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Group's La Jolla Pharmaceutical Company position peaked at $89K in Q3 2016.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.